In summary, lymph node metastasis, lesion length, tumor location, and serum CA199 and CEA levels may be factors affecting the poor prognosis of ESCC patients after minimally invasive resection. The gene discussed is CEACAM5; the disease is metastatic malignant neoplasm in the lymph nodes.